✦ LIBER ✦

Aromatic sialic acid analogues as potential inhibitors of influenza virus neuraminidase

✍ Scribed by Armandodoriano Bianco; Mario Brufani; Cristiana Melchioni

Book ID: 114018940
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 92 KB
Volume: 56
Category: Article
ISSN: 0014-827X
DOI: 10.1016/s0014-827x(01)01081-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Aromatic Sialic Aci

ChemInform Abstract: Aromatic Sialic Acid Analogues as Potential Inhibitors of Influenza Virus Neuraminidase.

✍ Armandodoriano Bianco; Mario Brufani; Cristiana Melchioni 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 29 KB 👁 2 views

Synthesis and influenza neuraminidase in

Synthesis and influenza neuraminidase inhibitory activity of aromatic analogues of sialic acid

✍ Matthew Williams; Norbert Bischofberger; S. Swaminathan; Choung Un Kim 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 183 KB

ChemInform Abstract: Synthesis and Influ

ChemInform Abstract: Synthesis and Influenza Neuraminidase Inhibitory Activity of Aromatic Analogues of Sialic Acid.

✍ M. WILLIAMS; N. BISCHOFBERGER; S. SWAMINATHAN; C. U. KIM 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 35 KB

Synthesis of a carbocyclic sialic acid a

Synthesis of a carbocyclic sialic acid analogue for the inhibition of influenza virus neuraminidase

✍ Armandodoriano Bianco; Mario Brufani; Fedele Manna; Cristiana Melchioni 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 150 KB

ChemInform Abstract: Synthesis of a Carb

ChemInform Abstract: Synthesis of a Carbocyclic Sialic Acid Analogue for the Inhibition of Influenza Virus Neuraminidase.

✍ Armandodoriano Bianco; Mario Brufani; Fedele Manna; Cristiana Melchioni 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 33 KB 👁 2 views

Development of neuraminidase inhibitors

Development of neuraminidase inhibitors as anti-influenza virus drugs

✍ Joseph N. Varghese 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 749 KB

Structure-based design and synthesis of potent influenza virus neuraminidase inhibitors are now being evaluated in human trials as anti-influenza virus drugs. The first drug of this class, Relenza™ (Zanamivir/GG167), is now awaiting pharmaceutical evaluation and registration in Australia, Europe, an